Followers | 65 |
Posts | 4647 |
Boards Moderated | 0 |
Alias Born | 02/12/2013 |
Monday, August 24, 2020 7:46:19 PM
EPIC LOSSES
NO CORONA AND LIME
BEER MONEY TRAPPED FOREVER
#ROFLMFAO #EatLOSSES
Recent XERS News
- Xeris to Participate in Upcoming Investor Conferences • Business Wire • 08/22/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:06:56 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 08:27:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:15:47 AM
- Xeris Biopharma Reports Second Quarter 2024 Financial Results • Business Wire • 08/08/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:22:39 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 09:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:14:16 PM
- Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024 • Business Wire • 07/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:14:32 AM
- Xeris Biopharma Announces CEO Succession Plan • Business Wire • 07/08/2024 11:00:00 AM
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 07/03/2024 05:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:19:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:15:27 PM
- Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024 • Business Wire • 06/03/2024 11:00:00 AM
- Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121) • Business Wire • 05/30/2024 11:30:00 AM
- Xeris to Participate in the Jefferies Global Healthcare Conference • Business Wire • 05/30/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:14:33 AM
- Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events • Business Wire • 05/09/2024 11:00:00 AM
- Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics • Business Wire • 05/06/2024 11:00:00 AM
- Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 05/02/2024 11:00:00 AM
- Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 04/03/2024 08:05:00 PM
- Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/02/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/06/2024 09:19:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/06/2024 09:10:13 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM